NEW DELHI Involving a set of new financial powers for emergency procurements sanctioned by the Defence Ministry earlier this month, the India Army is in the process of procuring Spike-LR Anti-Tank Missiles from Israel and Igla-S Very Short Range Air Defence Systems (VSHORAD) from Russia.
Under the latest emergency financial powers, armed forces have been given a free hand to procure equipment worth upto ?300 crore on a priority basis. The Request For Proposal (RFP) for the two deals have been issued and negotiations are ongoing, source were quoted as saying by a newspaper The Hindu.
Entirely new systems not in use can also be procured under the new powers, the source stated.
Tenders for both deals went on through regular procurement process earlier. While Spike tender was cancelled during the cost negotiation phase, the deal for Igla, after repeated delays, is in the cost negotiation phase. However, given the questions that were raised in the earlier deals, clarity is needed on the modalities for purchase through the emergency route.
Under the emergency route, the Army is looking to procure about 12 launchers and around 250 missiles for each system.
The Spike-LR (Long Range) being procured is a different variant from the one tested and shortlisted as part of the earlier procurement for over 8,000 missiles and 300 launchers along with technology transfer. As contract negotiations dragged on, the deal was cancelled in January last year and it was decided to procure a smaller number 170 launchers, 4,500 missiles and 15 simulators through an Inter-Governmental Agreement (IGA) and make up the balance requirement with an indigenous Man Portable ATGM, currently under development.
Before the IGA was concluded, validatory trials of the Infrared Seeker (IR) of the missile were to be held during the Indian summers as the missile did not perform as desired in the previous trials during peak summer temperatures in the desert, according to another source. However, the IGA has not made progress so far.
The Spike-LR (Long Range) has a range of 4 km. It is so far not clear if additional trials would be performed as part of this.
Be Part of Quality Journalism